3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
4
Interventional
1
Sponsor
Cancer Type
Other
7
Genitourinary
7
Gastrointestinal
5
Breast
3
CNS
2
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Leukemia, Myeloid, Acute
3100
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2085
Leukemia
2012
Leukemia, Lymphocytic, Chronic, B-Cell
1771
Myelodysplastic Syndromes
1298
Hematologic Neoplasms
1066
Lymphoma
1029
Lymphoma, Non-Hodgkin
981
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
713
Lymphoma, Follicular
704
Lymphoma, Mantle-Cell
678
Lymphoma, Large B-Cell, Diffuse
657
Burkitt Lymphoma
642
Multiple Myeloma
639
Lymphoma, B-Cell, Marginal Zone
599
Recurrence
587
Hodgkin Disease
575
Leukemia, Myelomonocytic, Chronic
495
Lymphoma, Large-Cell, Immunoblastic
419
Myeloproliferative Disorders
402
Neoplasms
401
Leukemia, Myeloid, Chronic-Phase
391
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
382
Congenital Abnormalities
357
Waldenstrom Macroglobulinemia
330
Blast Crisis
324
Leukemia, Myeloid, Accelerated Phase
290
Lymphoma, T-Cell, Cutaneous
280
Primary Myelofibrosis
270
Anemia, Refractory, with Excess of Blasts
251
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Metabolic Syndrome
×
Other hematologic neoplasm
×
Clear all
NCT04706676
2025-06-11
INTERACT
Rigshospitalet, Denmark
Phase NA
Active not recruiting
132 enrolled